Unicycive Therapeutics (UNCY) Stock: Buy, Sell, or Hold?
UNCY - Unicycive Therapeutics, Inc. Common Stock
$5.29
-0.02 (-0.38%)
▼
5d:
-0.19%
30d:
-1.86%
90d:
-31.21%
BUY
MODERATE Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When UNCY Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: UNCY shows positive signals but monitor for confirmation. Market pricing in 43.1% growth. Moderate conviction.
💡 BUY OPPORTUNITY: UNCY shows positive signals but monitor for confirmation. Market pricing in 43.1% growth. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$2.57
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$1.60
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 1.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: UNCY is currently trading at $5.29, which is considered fair relative to its 30-day fair value range of $5.10 to $5.49. From a valuation perspective, the stock is trading at a premium (Forward PE: 3.7) compared to its historical average (1.3). At these levels, the market is pricing in 43.1% annual earnings growth. This is a high bar to clear, indicating the stock may be priced for perfection.
Technical Outlook: Technically, UNCY is in a strong downtrend. Immediate support is located at $5.01, while resistance sits at $5.62.
Market Sentiment: UNCY scores 66/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $28.22 (+433.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, UNCY is in a strong downtrend. Immediate support is located at $5.01, while resistance sits at $5.62.
Market Sentiment: UNCY scores 66/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $28.22 (+433.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$5.10 -
$5.49
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
78.6%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (66/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 433.5% below Wall St target ($28.22)
- BEARISH: Market expects 43.1% growth - appears too optimistic based on history
- BULLISH: Bottoming setup score 66/100 — corrected, stabilizing, and turning up
Trading Range Analysis
30-Day Trading Range
$5.10 -
$5.49
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$5.01
Resistance Level
$5.62
Current Trend
Strong Downtrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
3.74
Wall Street Target
$28.22
(+433.5%)
Valuation Premium vs History
+43.1% premium
PE vs Historical
3.7 vs 1.3
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+43.1%
(market-implied from PE analysis)
1-Year Target
$7.57
(+43%)
2-Year Target
$10.83
(+105%)
3-Year Target
$15.50
(+193%)
3-Yr Target (if PE normalizes)
(PE: 4→1)
PE COMPRESSION
$5.38
(+2%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: September 13, 2026 10:07 AM ET
Data refreshes hourly during market hours. Next update: 11:07 AM
Data refreshes hourly during market hours. Next update: 11:07 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is UNCY showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 52 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$84 | 50 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$27 | 49 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 50 HOLD |
